Toward MSC in Solid Organ Transplantation: 2008 Position Paper of the MISOT Study Group
Marc H. Dahlke(Robert Bosch Hospital), Carla C. Baan(Erasmus MC), Pompiliu Piso(Krankenhaus Barmherzige Brüder), Sinda Bigenzahn(Vienna General Hospital), Felix Popp(University of Regensburg), Giuseppe Remuzzi(Mario Negri Institute for Pharmacological Research), Philipp Renner(Robert Bosch Hospital), Patrick Bertolino(Royal Prince Alfred Hospital), Chiara Capelli(Azienda Ospedaliero-Universitaria delle Marche), Martino Introna(Mario Negri Institute for Pharmacological Research), Hillard M. Lazarus(University Hospitals of Cleveland), Edward K. Geissler(University Hospital Regensburg), Hans‐Dieter Volk(Humboldt-Universität zu Berlin), Eliana Gotti(Azienda Ospedaliero-Universitaria delle Marche), Martina Seifert(University of Alabama at Birmingham), Benedetta Mazzanti(University of Florence), Alessandro Rambaldi(Ospedale Papa Giovanni XXIII), Thomas Wekerle(Brigham and Women's Hospital), Riccardo Saccardi(Azienda Ospedaliero-Universitaria Careggi), Martin J. Hoogduijn(Erasmus MC), Federica Casiraghi(Mario Negri Institute for Pharmacological Research), Hans J. Schlitt(University Hospital Regensburg), Norberto Perico(Mario Negri Institute for Pharmacological Research), Bart van Hoek(Leiden University Medical Center), Uta Kunter(RWTH Aachen University), Claudia Lange(Universität Hamburg), Marina Noris(Mario Negri Institute for Pharmacological Research), Hein W. Verspaget(Leiden University Medical Center), Robert Deans(Rubius Therapeutics (United States)), Amelia Bartholomew(University of Illinois Urbana-Champaign), Elke Eggenhofer(University Hospital Regensburg), Przemyslaw Slowik(University of Regensburg), Dominique Chabannes(Institut de Transplantation Urologie en Nephrologie)
Cited by 71
Related Papers
Predicting survival after liver transplantation in patients with hepatocellular carcinoma beyond the Milan criteria: a retrospective, exploratory analysis
|The Lancet Oncology|2008|2k
Prognostic Relevance of Integrated Genetic Profiling in Acute Myeloid Leukemia
|New England Journal of Medicine|2012|1.9k
von Willebrand Factor–Cleaving Protease in Thrombotic Thrombocytopenic Purpura and the Hemolytic–Uremic Syndrome
|New England Journal of Medicine|1998|1.7k
Retinoic Acid and Arsenic Trioxide for Acute Promyelocytic Leukemia
|New England Journal of Medicine|2013|1.6k